Pexidartinib

Pexidartinib is a capsule formulation containing a small-molecule receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3 with potential antineoplastic activity.

Price Not Available 50 mg Pexidartinib Supplier Page

Catalog Number	T2115
Alternative Name(s)	PLX-3397
Research Area	Angiogenesis\|\|\|Tyrosine Kinase/Adaptors\|\|\|Apoptosis
Molecular Formula	C20H15ClF3N5
CAS#	1029044-16-3
Purity	99.66%
SMILES	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1
Size	50 mg
Supplier Page	https://www.targetmol.com/compound/Pexidartinib
Additional Information	https://www.targetmol.com/datasheet/T2115